You have 9 free searches left this month | for more free features.

Neoplasms

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastroenteropancreatic Neuroendocrine Tumours

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
  • Milano, Italy
    Irccs San Raffaele
Nov 24, 2023

Pancreas Tumor, Stomach Tumor, Gastrointestinal Tumors Trial (EO-3021)

Not yet recruiting
  • Pancreas Neoplasm
  • +5 more
  • (no location specified)
Jul 31, 2023

T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

Not yet recruiting
  • T-Cell Neoplasm
  • Lymphoproliferative Disorders
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Oct 6, 2022

Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

Not yet recruiting
  • Lung Cancer
  • +8 more
  • Ion Endoluminal System
  • Orlando, Florida
  • +2 more
Aug 16, 2023

Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)

Not yet recruiting
  • Brain Tumor
  • Stanford, California
    Stanford Cancer Center
Nov 9, 2022

Colorectal Tumors Trial (Fecal immunochemical test, APCS score)

Not yet recruiting
  • Colorectal Neoplasms
  • Fecal immunochemical test
  • APCS score
  • (no location specified)
Jun 29, 2022

Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

Not yet recruiting
  • Bone Marrow Fibrosis
  • Myeloproliferative Neoplasm
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023

Glioma, Blood Platelets, Inflammation Trial in Paris (Platelet count in excised tumors)

Not yet recruiting
  • Glioma
  • +3 more
  • Platelet count in excised tumors
  • Paris, France
    Fondation A De Rothschild
Jun 8, 2022

Monocytes Sub-populations in Thrombosis Associated With

Recruiting
  • Myeloproliferative Neoplasm
  • 1 additional tube of blood
  • Bordeaux, France
  • +4 more
Nov 30, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Esophagogastric Histopathology Potentially Guided Patients

Not yet recruiting
  • Colorectal Neoplasms
    • (no location specified)
    Apr 26, 2023

    CNS Tumor, Head and Neck Tumors Trial in Memphis (L-(11C) methionine)

    Available
    • Central Nervous System Tumor
    • Head and Neck Neoplasms
    • L-(11C) methionine
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 19, 2022

    Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

    Not yet recruiting
    • Ovarian Neoplasms
    • +5 more
    • (no location specified)
    Sep 3, 2023

    Peritoneal Carcinomatosis, Appendiceal Tumors, Colorectal Cancer Metastatic Trial in Montréal (Modified early post-operative

    Not yet recruiting
    • Peritoneal Carcinomatosis
    • +2 more
    • Modified early post-operative intraperitoneal chemotherapy (mEPIC)
    • Montréal, Quebec, Canada
      Hôpital Maisonneuve-Rosemont
    Jun 12, 2023

    Tumor, Stomach, Tumor, Colorectal, Tumor, Esophagus Trial in Bucharest (Endoscopic submucosal dissection (ESD))

    Recruiting
    • Neoplasm, Stomach
    • +3 more
    • Endoscopic submucosal dissection (ESD)
    • Bucharest, Romania
      "Agrippa Ionescu" Hospital
    Sep 10, 2023

    Tumors Trial in Tijuana (Neoantigen Peptides)

    Recruiting
    • Neoplasms
    • Neoantigen Peptides
    • Tijuana, Baja California, Mexico
      Instituto de Medicina Regenerativa
    Jul 22, 2022

    Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)

    Recruiting
    • Advanced Solid Tumors
    • +3 more
    • IM96 CAR-T cells
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Mar 10, 2022

    Colonic Tumors Malignant, Cecal Tumors Trial in Moscow (ileocecal resection with extended D3 lymphadenectomy., Right

    Recruiting
    • Colonic Neoplasms Malignant
    • Cecal Neoplasms
    • ileocecal resection with extended D3 lymphadenectomy.
    • Right hemicolectomy with D3 lymphadenectomy.
    • Moscow, Russian Federation
      Moscow Clinical Scientific Center
    Nov 5, 2023

    Neuroendocrine Neoplasms Methylation Based Classifier - The

    Enrolling by invitation
    • Neuroendocrine Tumors
    • Methylation analysis
    • Basel, Basel Stadt, Switzerland
      University Hospital Basel, Department of Endocrinology
    May 17, 2022

    Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Colorectal Tumors Trial (Qualitative Fecal immunochemical test + APCS score, Quantitative Fecal immunochemical test)

    Not yet recruiting
    • Colorectal Neoplasms
    • Qualitative Fecal immunochemical test + APCS score
    • Quantitative Fecal immunochemical test
    • (no location specified)
    Jun 29, 2022

    Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin Trial in Beijing (Experimental: FOLFOXIRI and Lateral lymph node

    Enrolling by invitation
    • Lymph Node Metastasis
    • +6 more
    • Experimental: FOLFOXIRI and Lateral lymph node dissection
    • Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
    Sep 15, 2023

    Myeloproliferative Tumors Trial in Canada, Spain, United States (VAC85135, Ipilimumab)

    Recruiting
    • Myeloproliferative Neoplasms
    • Birmingham, Alabama
    • +16 more
    Jan 27, 2023

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

    Recruiting
    • Neoplasms
    • +12 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Oct 28, 2023